Literature DB >> 10091449

Who bears the burden of Medicaid drug copayment policies?

B Stuart1, C Zacker.   

Abstract

This DataWatch examines the impact of Medicaid prescription drug copayment policies in thirty-eight states using survey data from the 1992 Medicare Current Beneficiary Survey. Findings indicate that elderly and disabled Medicaid recipients who reside in states with copay provisions have significantly lower rates of drug use than their counterparts in states without copayments. After controlling for other factors, we find that the primary effect of copayments is to reduce the likelihood that Medicaid recipients fill any prescription during the year. This burden falls disproportionately on recipients in poor health.

Mesh:

Year:  1999        PMID: 10091449     DOI: 10.1377/hlthaff.18.2.201

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  27 in total

1.  Policy statements adopted by the Governing Council of the American Public Health Association, November 15, 2000.

Authors: 
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

Review 2.  The association of depression with adherence to antihypertensive medications: a systematic review.

Authors:  Chete M Eze-Nliam; Brett D Thombs; Bruno B Lima; Cheri G Smith; Roy C Ziegelstein
Journal:  J Hypertens       Date:  2010-09       Impact factor: 4.844

Review 3.  Consumer-directed health care: will it improve health system performance?

Authors:  Karen Davis
Journal:  Health Serv Res       Date:  2004-08       Impact factor: 3.402

Review 4.  Pharmacy utilization and the Medicare Modernization Act.

Authors:  Vittorio Maio; Laura Pizzi; Adam R Roumm; Janice Clarke; Neil I Goldfarb; David B Nash; David Chess
Journal:  Milbank Q       Date:  2005       Impact factor: 4.911

5.  Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic medicaid population.

Authors:  Seung Jin Bae; A David Paltiel; Anne L Fuhlbrigge; Scott T Weiss; Karen M Kuntz
Journal:  Value Health       Date:  2008 Jan-Feb       Impact factor: 5.725

6.  Implementation of the Medicare Part D prescription drug benefit is associated with antiretroviral therapy interruptions.

Authors:  Moupali Das-Douglas; Elise D Riley; Kathleen Ragland; David Guzman; Richard Clark; Margot B Kushel; David R Bangsberg
Journal:  AIDS Behav       Date:  2008-05-16

7.  The effect of pharmacy benefit design on patient-physician communication about costs.

Authors:  William H Shrank; Sarah A Fox; Adele Kirk; Susan L Ettner; Clairessa H Cantrell; Peter Glassman; Steven M Asch
Journal:  J Gen Intern Med       Date:  2006-04       Impact factor: 5.128

8.  Sensitivity of medication use to formulary controls in medicare beneficiaries: a review of the literature.

Authors:  Rahul Shenolikar; Amanda Schofield Bruno; Michael Eaddy; Christopher Cantrell
Journal:  Am Health Drug Benefits       Date:  2011-11

9.  The effects of Medicaid policy changes on adults' service use patterns in Kentucky and Idaho.

Authors:  James Marton; Genevieve M Kenney; Jennifer E Pelletier; Jeffery Talbert; Ariel Klein
Journal:  Medicare Medicaid Res Rev       Date:  2013-02-01

10.  How Low-Income Subsidy Recipients Respond to Medicare Part D Cost Sharing.

Authors:  Bruce Stuart; Franklin B Hendrick; Jing Xu; J Samantha Dougherty
Journal:  Health Serv Res       Date:  2016-06-20       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.